| Issue Date | Title | Author(s) |
| 2024-05 | An overview of hyphenated techniques used for the identification of genotoxic impurities in pharmaceutical products: Current status and future perspectives | Birla, D; Khandale, N; Ravindra Babu, M; Bashir, B; Shahbaz Alam, M; Vishwas, S; Chaitanya, MVNL; Gupta, G; Kumar Chellappan, D; Chawla, R; Singh, M; Dua, K; Kumar Singh, S |
| - | Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices | Birla, D; Khandale, N; Bashir, B; ShahbazAlam, M; Vishwas, S; Gupta, G; Dureja, H; Kumbhar, PS; Disouza, J; Patravale, V; Veiga, F; Paiva-Santos, AC; Pillappan, R; Paudel, KR; Goh, BH; Singh, M; Dua, K; Singh, SK |
| - | Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery | Gunjal, P; Vishwas, S; Kumar, R; Bashir, B; Kumar, B; Khurana, N; Gulati, M; Gupta, G; Prasher, P; Kumbhar, P; Disouza, J; Kuppusamy, G; Mohammed, Y; Dureja, H; Dua, K; Singh, SK |
| 2023-12-01 | Harnessing the neuroprotective effect of oral administration of benfotiamine in MPTP induced Parkinson's disease in rats. | Bashir, B; Mittal, S; Muthukumar, A; Vishwas, S; Pandey, NK; Gulati, M; Gupta, G; Dhanasekaran, M; Kumar, P; Dureja, H; Veiga, F; Paiva-Santos, AC; Adams, J; Dua, K; Singh, SK |
| 2024-02-16 | Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation. | Bashir, B; Alam, S; Khandale, N; Birla, D; Vishwas, S; Pandey, NK; Gupta, G; Paudel, KR; Dureja, H; Kumar, P; Singh, TG; Kuppusamy, G; Zacconi, F; Pinto, TDJA; Dhanasekaran, M; Gulati, M; Dua, K; Singh, SK |
| - | Unravelling role of crocin for the treatment of Alzheimer’s and Parkinson’s disease: sojourn from food to nanomedicine | Kaur, H; Bashir, B; Kaur, A; Singh, N; Vishwas, S; Kumar, P; Dureja, H; Chaitanya, MVNL; Singh, TG; Gupta, G; Alam, A; Veiga, F; Paiva-Santos, AC; Dua, K; Singh, SK |
